NIH Grants Shuttered: Researchers Join ACLU Lawsuit Against Trump’s ‘Ideological Purge’

November 16, 2025

Summary

A group of scientific researchers has filed a lawsuit against the National Institutes of Health (NIH) to reinstate their grant funding that was canceled by the Trump administration. The grants, worth over $1.1 billion, funded research on various topics including LGBTQ health, COVID-19, and vaccine hesitancy. The researchers argue that NIH exceeded its authority and acted arbitrarily in canceling the grants without providing adequate explanations.

Grant Funding Cancellation Sparks Lawsuit

The lawsuit was filed by the American Civil Liberties Union (ACLU) on behalf of four researchers, the American Public Health Association, the Ibis Reproductive Health, and the United Auto Workers union. The plaintiffs argue that NIH’s decision to cancel the grants is a direct attack on public health, particularly for marginalized communities.

According to Olga Akselrod, a lawyer with the ACLU’s Racial Justice Program, "The NIH’s efforts to shut down research that so much as references LGBTQ people or racial minorities is a direct attack on public health." The lawsuit claims that NIH exceeded its statutory authority and acted arbitrarily in canceling the grants without providing adequate explanations for how those studies fell below its standards for scientific research.

Background of Grant Funding Cancellation

The funding cuts are part of Trump’s wide-ranging actions to reshape the government, slash federal spending, and end government support for diversity, equity, and inclusion programs and transgender healthcare. In line with this policy agenda, NIH began instructing staff to terminate grant funding for studies related to DEI programs, transgender issues, and any that could potentially benefit Chinese universities.

In subsequent guidance on March 25, NIH instructed staff on how to terminate grants funding research into COVID-19, citing the end of the pandemic, and ways to curb vaccine hesitancy. HHS Secretary Robert F. Kennedy described the mass layoffs of 10,000 staffers in health agencies as essential to streamline a bloated bureaucracy.

Impact on Research Community

The cancellation of grant funding will jeopardize the discovery of new treatments, curtail research concerning diseases including HIV and Alzheimer’s disease, and cause researchers to lose jobs, lawyers at the ACLU argue. Among the researchers suing over canceled grants are Dr. Brittany Charlton, the founding director of Harvard Medical School’s LGBTQ Health Center of Excellence, and Dr. Katie Edwards, a University of Michigan professor who researches preventing sexual violence among minority communities.

Details of the Lawsuit

The complaint filed by the ACLU argues that NIH’s efforts to shut down research on certain topics amounts to an "ideological purge." The lawsuit challenges the abrupt decision to revoke grant funding for hundreds of studies without providing adequate explanations for how those studies fell below NIH’s standards.

Defendants attempt to justify this ongoing ideological purge of hundreds of critical research projects because they assertedly have some connection to ‘gender identity’ or ‘Diversity, Equity, and Inclusion’ or other vague, now-forbidden language," the complaint says. The lawsuit seeks reinstatement of grant funding and an injunction against further cancellations.

Conclusion

The impact of the canceled grants goes beyond the research community, potentially affecting the health and well-being of marginalized communities who rely on the findings of these studies. The decision by President Trump and NIH to cancel grant funding for certain research topics has sparked a heated debate about the role of government-funded science and the potential consequences of such actions.

The lawsuit filed by the ACLU highlights the importance of protecting public health and advancing scientific knowledge through continued funding for critical research projects. As the case unfolds, it will shed light on the complexities of federal funding for biomedical and behavioral research and its impact on marginalized communities.